Cited by 442Tuberculosis Research and EpidemiologyMicrobial Natural Products and BiosynthesisInfectious Diseases and Tuberculosis

Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane

Open access
Grzegorzewicz, Anna E, Pham, Ha, Gundi, Vijay A K B, Scherman, Michael S, North, Elton J, Hess, Tamara, Jones, Victoria, Gruppo, Veronica +8 more·2012·Nature Chemical Biology

Abstract

New chemotherapeutics active against multidrug-resistant Mycobacterium tuberculosis are urgently needed. We report on the identification of an adamantyl urea compound that shows potent bactericidal activity against M. tuberculosis and a unique mode of action, namely the abolition of the translocation of mycolic acids from the cytoplasm, where they are synthesized to the periplasmic side of the plasma membrane and are in turn transferred onto cell wall arabinogalactan or used in the formation of virulence-associated, outer membrane, trehalose-containing glycolipids. Whole-genome sequencing of spontaneous-resistant mutants of M. tuberculosis selected in vitro followed by genetic validation experiments revealed that our prototype inhibitor targets the inner membrane transporter MmpL3. Conditional gene expression of mmpL3 in mycobacteria and analysis of inhibitor-treated cells validate MmpL3 as essential for mycobacterial growth and support the involvement of this transporter in the translocation of trehalose monomycolate across the plasma membrane.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nchembio.794

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Knockdown of mmpL3 in M. smegmatis results in accumulation of the mycolate carrier trehalose monomycolate (TMM).

    “Knockdown of the mmpL3 gene in M. smegmatis is lethal, and results in reduced levels of outer membrane mycolic acids and the accumulation of the mycolate carrier, trehalose monomycolate (TMM), suggesting a role in mycolic acid transport (150, 151).”

    From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [151]

    The Results section ('Phenotypic effects of modulating mmpL3 expression'; page unavailable) reports that reduced mmpL3 expression in M. smegmatis decreased TDM formation and mycolic-acid transfer to AG. The Discussion (page unavailable) reports TMM accumulation in AU1235-treated M. tuberculosis, but our copy does not report TMM accumulation following mmpL3 knockdown in M. smegmatis. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Knockdown of mmpL3 in M. smegmatis results in reduced levels of outer membrane mycolic acids.

    “Knockdown of the mmpL3 gene in M. smegmatis is lethal, and results in reduced levels of outer membrane mycolic acids and the accumulation of the mycolate carrier, trehalose monomycolate (TMM), suggesting a role in mycolic acid transport (150, 151).”
  • Knockdown of the mmpL3 gene in M. smegmatis is lethal.

    “Knockdown of the mmpL3 gene in M. smegmatis is lethal, and results in reduced levels of outer membrane mycolic acids and the accumulation of the mycolate carrier, trehalose monomycolate (TMM), suggesting a role in mycolic acid transport (150, 151).”
  • MmpL3 has a role in mycolic acid transport.

    “suggesting a role in mycolic acid transport (150, 151)”
  • Early inhibitors of MmpL3 were discovered by screening chemical libraries for activity against M. tuberculosis growth and mapping resistance mutations back to the mmpL3 gene.

    “Early inhibitors of MmpL3 were discovered by screening chemical libraries for activity against M. tuberculosis growth and mapping resistance mutations back to the mmpL3 gene (151).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [2]Global Alliance for TB Drug Development. Scientific Blueprint for TB Drug Development Tuberculosis 81 1 52 2001 11530398

Cited by

Sorted by citations

Authors
Grzegorzewicz, A. E., Pham, H., Gundi, V. A. K. B., Scherman, M. S., North, E. J., Hess, T., Jones, V., Gruppo, V., Born, S. E. M., Korduláková, J., Chavadi, S. S., Morisseau, C., Lenaerts, A. J., Lee, R. E., McNeil, M. R., & Jackson, M.
Affiliations
  • Colorado State University (US)
  • St. Jude Children's Research Hospital (US)
  • Comenius University Bratislava (SK)
  • UC Davis Comprehensive Cancer Center (US)
Corresponding author
  • McNeil, Michael R
  • Jackson, Mary
Venue
Nature Chemical Biology
Published
2012-02-19
Volume
8
Issue
4
Pages
334-341
ISSN
  • 1552-4450 (ISSN-L)
  • 1552-4469
OpenAlex
W1996907187
Cited by
442
References
48
Citations by year
2026: 17 · 2025: 29 · 2024: 24 · 2023: 33 · 2022: 29 · 2021: 28 · 2020: 46 · 2019: 37 · 2018: 31 · 2017: 33 · 2016: 33 · 2015: 25 · 2014: 36 · 2013: 27 · 2012: 14
FWCI
23.41
Type
journal article
Language
en
Open access
Locations
  • Nature Chemical Biology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Allergy and Infectious Diseases (AI085992, RC1AI085992, AI063054, P01AI057836, R01AI063054, AI057836)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Pharmacology › Microbial Natural Products and Biosynthesis
  • Health Sciences › Medicine › Surgery › Infectious Diseases and Tuberculosis
Keywords
Mycobacterium tuberculosis, MmpL3, multidrug resistance, trehalose monomycolate, plasma membrane transporters, cell wall biosynthesis, arabinogalactan, mechanism of action
MeSH terms
Adamantane, Anti-Bacterial Agents, Bacterial Proteins, Biological Transport, Cell Membrane, Cord Factors, Drug Evaluation, Preclinical, Microbial Sensitivity Tests, Mutation, Mycobacterium tuberculosis, Mycolic Acids, Phenylurea Compounds, Trehalose, Drug Resistance, Bacterial, Membrane Transport Proteins, Small Molecule Libraries

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review